
AMMB Holdings Bhd
(Dec 20, RM7.50)
Maintain neutral at RM7.26 with a target price of RM7.84: AMMB Holdings Bhd last Thursday announced that the group had reached an agreement with MetLife International Holdings Inc to seek regulatory approval for a proposed strategic collaboration involving AmLife Insurance Bhd and AmFamily Takaful Bhd (AmTakaful).
The proposed strategic partnership will result in MetLife owning 50% plus one share in AmLife with the remaining shares to be owned by AMMB, while AMMB will own 50% plus one share in AmTakaful with the remaining shares to be owned by MetLife.
Besides that, the proposal will see AmLife and AmTakaful enter into exclusive 20-year bancassurance and bancatakaful agreements for the distribution of life insurance and family takaful products through the distribution network of AMMB’s banking subsidiaries, AmBank (M) Bhd and AmIslamic Bank Bhd, across Malaysia.
The total consideration payable by MetLife is RM812 million upon completion, subject to customary adjustment.
The proposed strategic collaboration is subject to the prior written approval of Bank Negara Malaysia and/or the Minister of Finance.
We are positive on AMMB’s strategic collaboration with MetLife, which is the leading global insurance provider serving about 90 million customers worldwide. This is because we believe that such a partnership will yield synergistic benefits for the group through the transfer of MetLife’s expertise and technical know-how to AmLife and AmTakaful, while allowing the former to capitalise on AMMB’s extensive network to distribute its product offerings.
The announcement has also largely come within expectation. To recap, since the repurchase of Friends’ Life’s 30% stake in AmLife and AmTakaful businesses, the management has been exploring options to grow its life and takaful businesses and is open to strategic collaborations with a third party insurer to accelerate its expansion plan. The management had previously guided that it could finalise the strategic collaboration by the fourth quarter of this year.
Our estimations show that the group could realise exceptional gains of about RM500 million from the disposal of significant stakes in both its AmLife and AmTakaful operations to MetLife.
Nonetheless, we are maintaining our core earnings estimates of financial year 2014 to 2016 for the group, given that the disposal gains are non-recurring in nature, while the significant strategic benefits from this collaboration will be on a longer-term basis.
We are maintaining our “neutral” recommendation on the group with an unchanged target price of RM7.84. Our target price implied a 1.7 times calendar year 2014 price-to-book value and 15% return on equity based on our Gordon Growth valuation model. — Alliance IB Research, Dec 20

This article first appeared in The Edge Financial Daily, on December 23, 2013.